Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles.
Gillespie SH, DiNardo AR, Georghiou SB, Sabiiti W, Kohli M, Panzner U, Kontsevaya I, Hittel N, Stuyver LJ, Tan JB, van Crevel R, Lange C, Thuong TNT, Heyckendorf J, Ruhwald M, Heinrich N.
Gillespie SH, et al. Among authors: tan jb.
Lancet Microbe. 2024 May 9:S2666-5247(24)00085-5. doi: 10.1016/S2666-5247(24)00085-5. Online ahead of print.
Lancet Microbe. 2024.
PMID: 38735303
Review.